HARVARD BIOSCIENCE INC insider trading

HBIONASDAQ

$8.34+0.21 (+2.58%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+81.3%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26

Unlock quarterly net flow

Key players

JWJames W. GreenDirector5.3875%of company
JDJohn D. DukeChief Executive Officer3.954%of company
KAKatherine A. EadeDirector1.2888%of company
WSWilliam SniderDirector1.0666%of company
MTMark T. FrostChief Financial Officer1.0434%of company
SJStephen J. DenelskyDirector0.825%of company
SBSeth Benjamin BensonDirector0.6053%of company
RERobert E. GagnonDirector0.6053%of company
JCJennifer CoteChief Financial Officer0.3493%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
HBIO	Stephen J. DenelskyDirector	Open market purchase$48.7K	+90.9%	$4.87	$48.7K	Mar 17, 2026	Mar 18, 2026
HBIO	William SniderDirector	Open market purchase$41.1K	+36.0%	$4.85	$41.1K	Mar 17, 2026	Mar 18, 2026
HBIO	Mark T. FrostChief Financial Officer	Open market purchase$25K	+40.0%	$5.00	$25K	Mar 16, 2026	Apr 1, 2026
HBIO	William SniderDirector	Open market purchase$62.5K	+113.9%	$4.99	$62.5K	Mar 16, 2026	Mar 18, 2026
HBIO	John D. DukeChief Executive Officer	Open market purchase$25.1K	+5.0%	$5.01	$25.1K	Mar 16, 2026	Mar 17, 2026

End of history · 5 transactions